[CYCC] YoY Quarter Result on 31-Mar-2016 [#Q1]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
13-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- 9.87%
YoY- 38.09%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Revenue 0 0 0 139 512 396 212 -
PBT -2,110 -1,531 -1,861 -3,534 -5,675 -5,446 -3,356 -7.43%
Tax -268 -182 -306 -493 -763 -569 -258 0.63%
NP -1,842 -1,349 -1,555 -3,041 -4,912 -4,869 -3,082 -8.21%
Tax Rate - - - - - - - -
Total Cost 1,842 1,349 1,555 3,180 5,424 5,265 3,294 -9.22%
Ratio Analysis
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
NP Margin 0.00 0.00 0.00 -2,187.77 -959.38 -1,229.55 -1,453.77 -
Per Share
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
EPS -2.70 -2.25 -7.28 -20.51 -45.23 -59.83 -75.55 -42.59%
EPS Diluted -2.70 -2.25 -7.28 -20.51 -45.23 -59.83 -75.55 -42.59%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.